Medifast Stock Forecast, Price & News

Medifast's stock was trading at $70.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MED stock has increased by 113.7% and is now trading at $150.56.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Medifast.

Medifast is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Medifast.

Medifast Inc (NYSE:MED) announced its quarterly earnings results on Wednesday, August, 5th. The specialty retailer reported $1.96 EPS for the quarter, beating the Zacks' consensus estimate of $1.84 by $0.12. The specialty retailer had revenue of $220 million for the quarter, compared to the consensus estimate of $194.75 million. Medifast had a net margin of 10.04% and a return on equity of 68.55%.
View Medifast's earnings history.

Medifast declared a quarterly dividend on Thursday, September 10th. Investors of record on Tuesday, September 22nd will be given a dividend of $1.13 per share on Friday, November 6th. This represents a $4.52 annualized dividend and a yield of 3.00%. The ex-dividend date is Monday, September 21st.
View Medifast's dividend history.

4 Wall Street analysts have issued 1 year price targets for Medifast's stock. Their forecasts range from $180.00 to $230.00. On average, they anticipate Medifast's stock price to reach $206.67 in the next year. This suggests a possible upside of 37.3% from the stock's current price.
View analysts' price targets for Medifast.

Some companies that are related to Medifast include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), The Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Medifast's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Ingalls & Snyder LLC (0.42%), Chickasaw Capital Management LLC (0.26%), State of Alaska Department of Revenue (0.09%), Campbell Newman Asset Management Inc. (0.07%), Louisiana State Employees Retirement System (0.05%) and Avantax Advisory Services Inc. (0.04%). Company insiders that own Medifast stock include Carl E Sassano, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Michael A Hoer, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends for Medifast.

MED stock was sold by a variety of institutional investors in the last quarter, including First Midwest Bank Trust Division, Ingalls & Snyder LLC, Envestnet Asset Management Inc., Carroll Financial Associates Inc., First Citizens Bank & Trust Co., Crossmark Global Holdings Inc., FormulaFolio Investments LLC, and State of Alaska Department of Revenue. Company insiders that have sold Medifast company stock in the last year include Michael C Macdonald, and Scott Schlackman.
View insider buying and selling activity for Medifast.

MED stock was bought by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC, Louisiana State Employees Retirement System, Bowling Portfolio Management LLC, Nisa Investment Advisors LLC, Avantax Advisory Services Inc., Campbell Newman Asset Management Inc., Spearhead Capital Advisors LLC, and Chickasaw Capital Management LLC. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Jeffrey J Brown, and Michael A Hoer.
View insider buying and selling activity for Medifast.

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MED stock can currently be purchased for approximately $150.56.

Medifast has a market capitalization of $1.77 billion and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis. Medifast employs 420 workers across the globe.

The official website for Medifast is www.medifast1.com.

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]